Quarterly report pursuant to Section 13 or 15(d)

Summary of Significant Accounting Policies (Details Textual)

v3.7.0.1
Summary of Significant Accounting Policies (Details Textual) - USD ($)
3 Months Ended 6 Months Ended 12 Months Ended
Jun. 30, 2017
Jun. 30, 2016
Jun. 30, 2017
Jun. 30, 2016
Dec. 31, 2016
Summary of Significant Accounting Policies (Textual)          
Non-controlling interest rate     21.8333%    
Variable Interest Entity, assets $ 12,051   $ 12,051   $ 10,306
Variable Interest Entity, liabilities 18,481   18,481   5,748
Variable Interest Entity, revenues     1,507    
Variable Interest Entity, operating expenses     1,519    
Inventory reserve 20,000   20,000   20,000
Customer discounts, returns and rebates 12,000 $ 620,000 50,000 $ 1,050,000  
Revenue 1,107,418 1,227,247 1,531,880 2,868,275  
Accounts receivable reserve $ 37,800   37,800   37,800
Weighted average number of common stock 5,145,693        
Sales returns and allowances     $ 6,000   $ 50,500
Consolidated VIE, description     Company consolidated nine VIEs.   Company consolidated nine VIEs.
Noncontrolling interests, description     The Company accounts for its less than 100% interest in Immudyne PR in accordance with ASC Topic 810, Consolidation, and accordingly the Company presents noncontrolling interests as a component of equity on its consolidated balance sheet and reports the noncontrolling interest's share of the Immudyne PR net loss attributable to noncontrolling interests in the consolidated statement of operations.    
Income tax, description     More than 50    
Nutraceutical and Cosmetic Additives [Member]          
Summary of Significant Accounting Policies (Textual)          
Revenue $ 447,330 266,060 $ 703,893 551,220  
Finished Cosmetic Products [Member]          
Summary of Significant Accounting Policies (Textual)          
Revenue $ 660,088 $ 964,937 $ 827,987 $ 2,340,055  
Sales [Member] | One customer [Member] | Nutraceutical and Cosmetic Additives [Member]          
Summary of Significant Accounting Policies (Textual)          
Concentration risk percentage 35.00% 17.00% 42.00% 16.00%  
Accounts Receivable [Member] | One credit card processor [Member]          
Summary of Significant Accounting Policies (Textual)          
Concentration risk percentage     20.00%   35.00%
Accounts Receivable [Member] | Two credit card processor [Member]          
Summary of Significant Accounting Policies (Textual)          
Concentration risk percentage         32.00%
Accounts Receivable [Member] | One customer [Member]          
Summary of Significant Accounting Policies (Textual)          
Concentration risk percentage     60.00%   11.00%
Option [Member] | Warrant [Member]          
Summary of Significant Accounting Policies (Textual)          
Antidilutive securities excluded from computation of earnings per share     11,550,273 12,700,273